Host Immune Mechanisms in Infectious and Non-infectious Diseases in Humans

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".

Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 2107

Special Issue Editors


E-Mail Website
Guest Editor
Emory Vaccine Center, Division of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA
Interests: natural killer cells; immunology; microbiology; host immune mechanisms

E-Mail Website
Guest Editor
Emory Vaccine Center, Division of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA
Interests: immunology; microbiology; host immune mechanisms

E-Mail Website
Guest Editor
Emory Vaccine Center, Division of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA
Interests: immunology; microbiology; host immune mechanisms

Special Issue Information

Dear Colleagues,

The Immune system is an intricate network of proteins, cells, and various organs that acts as a potent host defense against pathogens, toxins, allergens, and tumor cells. Our immune system gradually matures during infancy. Subsequently, it undergoes major development during a lifetime of exposure to environmental antigens, hence, inducing a rapid evolution of the immune responses. A functioning immune system protects the host from foreign agents either by producing antibodies or recruiting various immune cells. The innate immune system, including neutrophils, monocytes, macrophages, and dendritic cells, provides the first line of defense against pathogens. It generates rapid, non-specific inflammatory responses to bacteria, viruses, and other pathogens. Innate immunity plays an important role in shaping the antigen-specific responses, also known as adaptive immunity. The ability of humans to survive in a world where they are re-exposed to pathogens throughout their lifetimes is due to memory T and B cells, which are the hallmark of adaptive immunity. A balanced interplay between various components in the immune system is important, otherwise it leads to immunological abnormalities. The abnormalities in the innate and adaptive immune system can lead to immunological deficiencies, allergies, or autoimmune diseases. Furthermore, age and sex have been reported to modulate immune responses differently against pathogens. For instance, males experienced severe outcomes compared to females during the recent SARS-CoV-2 pandemic. Moreover, growing evidence in the last few decades has shown that microbiota associated with organisms play a significant role in shaping immune responses and, thus, overall health. The use of immunotherapeutic treatment to treat cancer and immunological disorders is rapidly evolving. In order to achieve the desired outcome from these treatments, it is critical that we fully understand the host immune mechanism. Much has been learnt in this area, but there is still much to be understood. This Special Issue plans to give an overview of the most recent advances in the field of host immune mechanisms in infectious and non-infectious diseases in humans. We encourage reviews, research papers, and perspectives that provide a detailed report of the molecular and cellular variables at play across a variety of innate and adaptive cell types, signaling pathways, and responses in the context of infectious and non-infectious disorders. This Special Issue is also aimed at providing selected contributions on recent advances in our understanding of the relationship between sex, age, and immune functions, as well as the impact of gut microbiota in shaping the immunological responses.

Potential topics include, but are not limited to:

  • Innate immunity and inflammation
  • Gene regulation and recombination
  • Lymphocyte development and migration
  • Cell signaling
  • Autoimmune diseases
  • Effect of age and sex on the immune mechanisms
  • Role of gut microbiota in shaping immune system

Dr. Georges Khoury
Dr. Akil Akhtar
Dr. Rajesh Valanparambil
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

17 pages, 2249 KiB  
Review
Interplay of Chemokines Receptors, Toll-like Receptors, and Host Immunological Pathways
by Yuan-Tung Chu, Min-Tser Liao, Kuo-Wang Tsai, Kuo-Cheng Lu and Wan-Chung Hu
Biomedicines 2023, 11(9), 2384; https://doi.org/10.3390/biomedicines11092384 - 25 Aug 2023
Cited by 1 | Viewed by 1834
Abstract
A comprehensive framework has been established for understanding immunological pathways, which can be categorized into eradicated and tolerable immune responses. Toll-like receptors (TLRs) are associated with specific immune responses. TH1 immunity is related to TLR7, TLR8, and TLR9, while TH2 immunity is associated [...] Read more.
A comprehensive framework has been established for understanding immunological pathways, which can be categorized into eradicated and tolerable immune responses. Toll-like receptors (TLRs) are associated with specific immune responses. TH1 immunity is related to TLR7, TLR8, and TLR9, while TH2 immunity is associated with TLR1, TLR2, and TLR6. TH22 immunity is linked to TLR2, TLR4, and TLR5, and THαβ (Tr1) immunity is related to TLR3, TLR7, and TLR9. The chemokine receptor CXCR5 is a marker of follicular helper T cells, and other chemokine receptors can also be classified within a framework based on host immunological pathways. On the basis of a literature review on chemokines and immunological pathways, the following associations were identified: CCR5 with TH1 responses, CCR1 with TH1-like responses, CCR4 (basophils) and CCR3 (eosinophils) with TH2 and TH9 responses, CCR10 with TH22 responses, CCR6 with TH17 responses, CXCR3 with THαβ responses, CCR8 with regulatory T cells (Treg), and CCR2 with TH3 responses. These findings contribute to the identification of biomarkers for immune cells and provide insights into host immunological pathways. Understanding the chemokine and Toll-like receptor system is crucial for comprehending the function of the innate immune system, as well as adaptive immune responses. Full article
Show Figures

Figure 1

Back to TopTop